Study

Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test. – Cost Effective Supplements

Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test.

Quick navigation


http://www.ncbi.nlm.nih.gov/pubmed/2568712


Conclusion of this study

Thirty-three women with urinary stress incontinence were treated with the alpha-adrenoceptor-stimulating agent, norfenefrine (Nevadral Retard). Treatment was administered during 3-24 weeks at a daily dosage of 90 mg. Judged by a 1-hour pad weighing test, a significant effect could be demonstrated. With the exception of 1 case of allergic reaction and 1 case of recurrent vomiting, a simultaneously performed tolerability test revealed only minor side effects.


Supplements analyzed in this study

Octopamine

Health conditions analyzed in this study

Urinary Incontinence


Slightly Positive
Octopamine


Functions related to this study

Overall health


Slightly Positive
Octopamine


Body systems related to this study


Urinary System
Scroll to top